Eli Lilly & Co. vs STERIS plc
LLY vs STE — side-by-side comparison from reported financials. LLY leads 8, STE leads 4 of 12 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
| Metric | LLY | STE |
|---|---|---|
| Price | $1 177.20 | $214.40 |
| Market cap | $1.05T | $20.9B |
| Revenue (TTM) | $79.7B | $6.04B |
| Revenue growth | +31.7% | +6.2% |
| Net margin | 33.5% | 13.3% |
| Free cash flow | $18.2B | $926M |
| Net cash (debt) | ($35.2B) | ($1.65B) |
| 1-year price return | +37.6% | -10.5% |
| P/E | 41.6 | 26.0 |
| P/E vs own history (cheap-side %) | 88% | 97% |
| Dividend yield | 0.52% | 1.18% |
| Return on equity | 93% | 11% |
| Altman Z-score | 7.10 | 4.34 |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 50,000 | 17,937 |
Full résumé-style profiles: LLY CV · STE CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.